A CRISPR/Cas12a−MXene Nanozyme Platform for Universal Detection of Trace DNA
ACS Sensors · 26.06.2026 · 11 (6) · 4345-4356
DOI: 10.1021/acssensors.5c03702 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, online erschienen am 20.05.2026. Verfasst von Sufang Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian 350108, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Biosensing Techniques, CRISPR-Associated Proteins, DNA, Bacterial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Fuzhou University, Fujian Province Health and Medical Innovation Project, Fujian Cancer Hospital.
Abstract (Originalsprache)
The instrument-free detection of specific DNA sequences is critical for point-of-care diagnostics yet remains challenging. To address this, we developed a universal colorimetric biosensing platform integrating the CRISPR/Cas12a system with MXene nanozymes. Target recognition by the Cas12a/crRNA complex triggers trans-cleavage of single-stranded DNA inhibitors, restoring the peroxidase-like activity of MXenes to produce a visible signal. The platform achieved a detection limit of 132 copies/μL for the methicillin-resistant Staphylococcus aureus mecA gene. By incorporating an exponential circular DNA (CirDNA) amplification strategy and rationally designed crRNAs for single-base discrimination, sensitivity was further enhanced, enabling detection of the B-raf proto-oncogene V600E mutation down to 109 aM with 0.5% variant allele frequency. The platform also showed excellent reproducibility and high recovery rates in simulated clinical samples. This work provides a low-cost, label/instrument-free, and highly sensitive universal approach through the synergistic combination of CRISPR/Cas12a programmability, MXene nanozyme activity, and CirDNA amplification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian 350108, China.
- Department of Gastric Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014, China.
- Ministry of Education Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection for Food Safety, Fuzhou University, Fuzhou, Fujian 350108, China.
ORCID-Profile: Fang Zhang, Dianping Tang, Zuquan Weng
Förderung
- Fuzhou University
- Fujian Province Health and Medical Innovation Project
- Fujian Cancer Hospital
- Joint Funds for the innovation of Science, Fujian Province
Zitieren
APA
Liu, S., Hu, Y., Zheng, M., Zhang, F., Yu, Z., Sun, Q., Tang, D., Weng, Z., & Ye, Z. (2026). A CRISPR/Cas12a−MXene Nanozyme Platform for Universal Detection of Trace DNA. ACS Sensors, 11(6), 4345-4356. https://doi.org/10.1021/acssensors.5c03702
Vancouver
Liu S, Hu Y, Zheng M, Zhang F, Yu Z, Sun Q, et al. A CRISPR/Cas12a−MXene Nanozyme Platform for Universal Detection of Trace DNA. ACS Sensors. 2026;11(6):4345-4356. doi:10.1021/acssensors.5c03702
BibTeX
@article{Liu2026,
author = {Liu, Sufang and Hu, Yuanlong and Zheng, Miao and Zhang, Fang and Yu, Zhichao and Sun, Qi and Tang, Dianping and Weng, Zuquan and Ye, Zaisheng},
title = {A CRISPR/Cas12a−MXene Nanozyme Platform for Universal Detection of Trace DNA},
journal = {ACS Sensors},
year = {2026},
volume = {11},
number = {6},
pages = {4345--4356},
doi = {10.1021/acssensors.5c03702}
}
EUVIMED